321 related articles for article (PubMed ID: 38535481)
1. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine.
Inagaki M
J Dev Biol; 2023 Dec; 12(1):. PubMed ID: 38535481
[TBL] [Abstract][Full Text] [Related]
2. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
[TBL] [Abstract][Full Text] [Related]
3. Direct Reprogramming, Epigenetics, and Cardiac Regeneration.
Kurotsu S; Suzuki T; Ieda M
J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134
[TBL] [Abstract][Full Text] [Related]
4. [Induced pluripotent stem cell technology and its application in disease research].
Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
[TBL] [Abstract][Full Text] [Related]
5. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
6. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
Wang AYL
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
[TBL] [Abstract][Full Text] [Related]
7. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
Omole AE; Fakoya AOJ
PeerJ; 2018; 6():e4370. PubMed ID: 29770269
[TBL] [Abstract][Full Text] [Related]
8. mRNA-Based Genetic Reprogramming.
Warren L; Lin C
Mol Ther; 2019 Apr; 27(4):729-734. PubMed ID: 30598301
[TBL] [Abstract][Full Text] [Related]
9. Small-molecule-mediated reprogramming: a silver lining for regenerative medicine.
Kim Y; Jeong J; Choi D
Exp Mol Med; 2020 Feb; 52(2):213-226. PubMed ID: 32080339
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
11. Perspectives of induced pluripotent stem cells for cardiovascular system regeneration.
Csöbönyeiová M; Polák Š; Danišovič L
Exp Biol Med (Maywood); 2015 May; 240(5):549-56. PubMed ID: 25595188
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity risk of iPSCs
Zhong C; Liu M; Pan X; Zhu H
Precis Clin Med; 2022 Mar; 5(1):pbac004. PubMed ID: 35692443
[TBL] [Abstract][Full Text] [Related]
13. iPS Cells-The Triumphs and Tribulations.
Sharma R
Dent J (Basel); 2016 Jun; 4(2):. PubMed ID: 29563461
[TBL] [Abstract][Full Text] [Related]
14. Generation of induced pluripotent stem cells with high efficiency from human embryonic renal cortical cells.
Yao L; Chen R; Wang P; Zhang Q; Tang H; Sun H
Am J Transl Res; 2016; 8(11):4982-4993. PubMed ID: 27904699
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
16. Methods for Isolation and Reprogramming of Various Somatic Cell Sources into iPSCs.
Neeman-Egozi S; Baskin P; Binah O
Methods Mol Biol; 2022; 2454():643-655. PubMed ID: 34128204
[TBL] [Abstract][Full Text] [Related]
17. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
[TBL] [Abstract][Full Text] [Related]
18. Concise Review: Application of Chemically Modified mRNA in Cell Fate Conversion and Tissue Engineering.
Badieyan ZS; Evans T
Stem Cells Transl Med; 2019 Aug; 8(8):833-843. PubMed ID: 30891922
[TBL] [Abstract][Full Text] [Related]
19. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.
Warren L; Manos PD; Ahfeldt T; Loh YH; Li H; Lau F; Ebina W; Mandal PK; Smith ZD; Meissner A; Daley GQ; Brack AS; Collins JJ; Cowan C; Schlaeger TM; Rossi DJ
Cell Stem Cell; 2010 Nov; 7(5):618-30. PubMed ID: 20888316
[TBL] [Abstract][Full Text] [Related]
20. Clinical Application of Induced Pluripotent Stem Cells in Cardiovascular Medicine.
Chi HJ; Gao S; Yang XC; Cai J; Zhao WS; Sun H; Geng YJ
Cardiology; 2015; 131(4):236-44. PubMed ID: 25969168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
